Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Completed · Phase 3

Conditions studied: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

In brief

This open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing to achieve the desired level of glycemic control using insulin therapy.

Key facts

Study ID

NCT00108004

Run by

AstraZeneca

People needed

400

Starts

2003-04-01

Expected to finish

2005-06-01

Last updated by the study team

2015-05-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subject has a clinical diagnosis of type 1 diabetes mellitus requiring treatment with insulin for a minimum of 6 months at Screening; -OR- The subject has a clinical diagnosis of type 2 diabetes requiring treatment with insulin with or without oral antidiabetic agents for a minimum of 6 months at Screening.
• The subject has a HbA1c of 7.0% to 11.0% at Screening.

Where it is running

• Research Site — Anaheim, California, United States
• Research Site — Escondido, California, United States
• Research Site — La Jolla, California, United States
• Research Site — Los Gatos, California, United States
• Research Site — San Francisco, California, United States
• Research Site — Torrance, California, United States
• Research Site — New Britain, Connecticut, United States
• Research Site — Norwalk, Connecticut, United States
• Research Site — Norwich, Connecticut, United States
• Research Site — Washington D.C., District of Columbia, United States
• Research Site — Clearwater, Florida, United States
• Research Site — Orlando, Florida, United States
• Research Site — Columbus, Georgia, United States
• Research Site — Honolulu, Hawaii, United States
• Research Site — Idaho Falls, Idaho, United States
• Research Site — Indianapolis, Indiana, United States
• Research Site — Vincennes, Indiana, United States
• Research Site — Topeka, Kansas, United States
• Research Site — Wichita, Kansas, United States
• Research Site — Lexington, Kentucky, United States
• Research Site — Baltimore, Maryland, United States
• Research Site — Bloomfield Hills, Michigan, United States
• Research Site — Tupelo, Mississippi, United States
• Research Site — Las Vegas, Nevada, United States
• Research Site — Reno, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.